Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes.
Chemerin is a novel adipokine that is correlated with adipocyte differentiation, glucose metabolism, and inflammation. We aimed to investigate the relation between serum chemerin level and subclinical atherosclerosis markers as exemplified by brachial artery pulse wave velocity (baPWV), carotid intima-media thickness (CIMT), epicardial fat thickness (EFT), and carotid plaque presence in diabetes and prediabetes.



Age-, body mass index (BMI)-, and gender-matched patients with type 2 DM (n=30), prediabetes (n=25), and normal glucose tolerance (n=25) were included in this cross-sectional study. Serum chemerin level, lipid parameters, glucose metabolism marker, baPWV, CIMT, EFT, and anthropometric were recorded. The independent risk factors for atherosclerosis markers were determined by linear and/or multiple logistic regression analysis.



baPWV and carotid plaque presence were higher in the diabetes group than in prediabetes and control groups (p=0.039 and p=0.035 respectively), whereas serum chemerin levels were similar among groups (p=0.338). Chemerin levels were not correlated with PWV, CIMT, and epicardial fat thickness overall or in the subgroups. Overall and in the diabetes group, chemerin levels were positively correlated with the key components of metabolic syndrome as BMI, total body fat percentage, waist circumference, triglyceride, and systolic and diastolic blood pressure (BP). After adjusting for age, gender, and BMI, only the association between chemerin and systolic BP remained significant. Chemerin was not found as an independent risk factor for predicting atherosclerosis in diabetes and prediabetes.



Chemerin is not a predictive marker for atherosclerosis in diabetes and prediabetes, but correlates well with key aspects of the metabolic syndrome particularly in diabetes.
Department of Endocrinology and Metabolism, Faculty of Medicine, Hacettepe University, Ankara-Turkey.
Kadriye
K
Aydın
Department of Cardiology, Faculty of Medicine, Hacettepe University, Ankara-Turkey.
Uğur
U
Canpolat
Department of Endocrinology and Metabolism, Faculty of Medicine, Hacettepe University, Ankara-Turkey.
Şafak
Ş
Akın
Department of Cardiology, Faculty of Medicine, Hacettepe University, Ankara-Turkey.
Muhammet
M
Dural
Department of Biostatistics, Faculty of Medicine, Hacettepe University, Ankara-Turkey.
Jale
J
Karakaya
Department of Cardiology, Faculty of Medicine, Hacettepe University, Ankara-Turkey.
Kudret
K
Aytemir
Department of Cardiology, Faculty of Medicine, Hacettepe University, Ankara-Turkey.
Necla
N
Özer
Department of Endocrinology and Metabolism, Faculty of Medicine, Hacettepe University, Ankara-Turkey. agurlek2001@yahoo.com.
Alper
A
Gürlek